Corcept Therapeutics (CORT) shares rose 11.6% in Wednesday trading after UBS Securities upgraded the stock to buy from neutral and adjusted its price target to $72 per share from $44.
Trading volume stood at over 1.2 million shares compared with a daily average of about 1.7 million.
Price: $57.11, Change: $+5.95, Percent Change: +11.62%